Skip to main content
梓橦宫 logo

梓橦宫 — Investor Relations & Filings

Ticker · 920566 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 625 across all filing types
Latest filing 2022-05-11 Investor Presentation
Country CN China
Listing Beijing Stock Exchange 920566

About 梓橦宫

http://www.zitonggong.com/

Zitonggong specializes in the research, development, and production of specialized therapeutic agents. Established with a heritage dating back to 1780, the company holds a recognized heritage brand designation. Its primary product portfolio centers on neurological and cerebrovascular health, featuring Oxiracetam in various dosage forms for treating cognitive dysfunction and brain injuries. The company also develops treatments for digestive health, including Compound Aloe Capsules, and produces artificial Oriental Bezoar. Operations are centered on integrating traditional medicinal knowledge with modern chemical synthesis and manufacturing standards. The company maintains a focus on clinical efficacy and technological advancement in the fields of neurology and gastroenterology.

Recent filings

Filing Released Lang Actions
投资者关系活动记录表
Investor Presentation Classification · 95% confidence The document is titled as an "投资者关系活动记录表" which translates to "Investor Relations Activity Record". It specifically mentions that the activity is an "业绩说明会" or "Performance Explanation Meeting" related to the 2021 Annual Report. The content includes a Q&A session with management discussing the company's 2021 financial performance, strategic plans, product development, and shareholder returns. The document is a transcript or record of an investor presentation event rather than the actual annual report or financial statements. The length is 4228 characters, which is relatively short and consistent with a meeting summary or transcript rather than a full report. Therefore, this document fits best under the category of an Investor Presentation (IP).
2022-05-11 Chinese
2021年年度报告业绩说明会预告公告
AGM Information Classification · 95% confidence The document is a notice announcing a scheduled performance explanation meeting related to the company's 2021 Annual Report. It references the 2021 Annual Report and provides details about the meeting time, location, participants, and how investors can participate. The document does not contain the actual annual report or detailed financial data but rather announces the event to discuss the annual report. The document length is short (964 characters), and it explicitly states it is a notice for the annual report performance explanation meeting. According to the classification rules, such a document is best classified as AGM Information (AGM-R) because it relates to materials shared during an annual general meeting or similar shareholder meeting event, specifically an annual report performance explanation meeting.
2022-05-05 Chinese
2022年第一季度报告(更正公告)
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2022 First Quarter Report Correction Announcement" from Sichuan Zitonggong Pharmaceutical Co., Ltd. It references a previously published quarterly report for the period January to March 2022 and provides corrected financial data and explanations for the changes. The document contains detailed financial figures for the quarter, including revenue, net profit, earnings per share, and non-recurring gains/losses. The length of the document is 2868 characters, which is relatively short but contains substantive financial data and analysis for the quarter. It is not merely an announcement that a report is available, nor is it a certification or attestation. Therefore, it qualifies as an Interim / Quarterly Report (IR) because it provides comprehensive financial data and corrections for a period shorter than a full fiscal year (the first quarter). Q1 2022
2022-04-28 Chinese
关于药品生产许可证变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in the company's drug production license, specifically the change of the production responsible person. It is a regulatory announcement about a license update issued by a government authority (Sichuan Provincial Drug Administration). The document does not contain financial data, earnings, management changes, or detailed reports. It is a formal public notice about a regulatory permit change, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2022-04-28 Chinese
2022年第一季度报告（更正后）
Interim / Quarterly Report Classification · 95% confidence The document is titled "四川梓橦宫药业股份有限公司 2022 年第一季度报告" which translates to "Sichuan Zitonggong Pharmaceutical Co., Ltd. 2022 First Quarter Report." It includes detailed financial data such as balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the period January 1, 2022 to March 31, 2022. The document explicitly states it is a quarterly report and contains comprehensive financial statements and analysis for the quarter. It is unaudited but contains substantive financial data and management commentary. This matches the definition of an Interim / Quarterly Report (IR). The document length is about 15,000 characters, indicating it is the full report, not just an announcement. Therefore, the correct classification is IR with high confidence. Q1 2022
2022-04-28 Chinese
2022年第一季度报告披露提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (414 characters) indicating that the company's 2022 first quarter report has been approved and published on the official exchange platform. It does not contain the actual financial data or detailed report content but rather informs investors to refer to the full report elsewhere. This fits the criteria for a Report Publication Announcement (RPA) rather than the Interim/Quarterly Report (IR) itself, as per the 'Menu vs Meal' rule.
2022-04-28 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.